Lannett gains generic product portfolio from Endo subsidiary

09-05-2018

Lannett gains generic product portfolio from Endo subsidiary

sprng23 / iStockphoto.com

Generic drug manufacturer Lannett has acquired the product portfolio of an Endo International subsidiary.


Endo International, Lannett, generic drug manufacture, Tim Crew, generic drug portfolio, life sciences acquisition, oral products

LSIPR